These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19251402)

  • 1. Roxithromycin inhibits chemokine-induced chemotaxis of Th1 and Th2 cells but regulatory T cells.
    Ito T; Ito N; Hashizume H; Takigawa M
    J Dermatol Sci; 2009 Jun; 54(3):185-91. PubMed ID: 19251402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors.
    Kobayashi M; Shimauchi T; Hino R; Tokura Y
    Cell Immunol; 2004 Mar; 228(1):27-33. PubMed ID: 15203317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
    Morimoto Y; Bian Y; Gao P; Yashiro-Ohtani Y; Zhou XY; Ono S; Nakahara H; Kogo M; Hamaoka T; Fujiwara H
    J Leukoc Biol; 2005 Sep; 78(3):753-61. PubMed ID: 16126843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells.
    Wang L; Knudsen E; Jin Y; Gessani S; Maghazachi AA
    Cell Signal; 2004 Sep; 16(9):991-1000. PubMed ID: 15212760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
    Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
    J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell chemokine receptor expression in human Th1- and Th2-associated diseases.
    Campbell JD; HayGlass KT
    Arch Immunol Ther Exp (Warsz); 2000; 48(6):451-6. PubMed ID: 11197598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors involved in the T helper type 1 and type 2 cell commitment and osteoclast regulation in inflammatory apical diseases.
    Fukada SY; Silva TA; Garlet GP; Rosa AL; da Silva JS; Cunha FQ
    Oral Microbiol Immunol; 2009 Feb; 24(1):25-31. PubMed ID: 19121066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis.
    Nureki S; Miyazaki E; Ando M; Ueno T; Fukami T; Kumamoto T; Sugisaki K; Tsuda T
    Respir Med; 2008 Feb; 102(2):239-47. PubMed ID: 17949965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides.
    Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Th2 type cytokine production from human peripheral blood leukocytes by a macrolide antibiotic, roxithromycin, in vitro.
    Asano K; Kamakazu K; Hisamitsu T; Suzaki H
    Int Immunopharmacol; 2001 Oct; 1(11):1913-21. PubMed ID: 11606023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides.
    Hino R; Shimauchi T; Tokura Y
    J Dermatol Sci; 2005 Jun; 38(3):189-95. PubMed ID: 15927812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of ketotifen on Th1- and Th2-related chemokines of monocytes.
    Hung CH; Suen JL; Hua YM; Chiang W; Chang HC; Chen CN; Jong YJ
    Pediatr Allergy Immunol; 2007 Aug; 18(5):378-84. PubMed ID: 17617806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
    Kanai K; Asano K; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
    Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
    Mahendra A; Misra R; Aggarwal A
    J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
    Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
    Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diesel on chemokines and chemokine receptors involved in helper T cell type 1/type 2 recruitment in patients with asthma.
    Sénéchal S; de Nadai P; Ralainirina N; Scherpereel A; Vorng H; Lassalle P; Tonnel AB; Tsicopoulos A; Wallaert B
    Am J Respir Crit Care Med; 2003 Jul; 168(2):215-21. PubMed ID: 12724126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of CXCR6 and CXCR3 in lymphocytes from birch-allergic patients.
    Casas R; Lindau C; Zetterström O; Duchén K
    Scand J Immunol; 2008 Sep; 68(3):351-61. PubMed ID: 18782262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switch from a dominant Th1-associated immune profile during the pre-diabetic phase in favour of a temporary increase of a Th3-associated and inflammatory immune profile at the onset of type 1 diabetes.
    Ryden A; Stechova K; Durilova M; Faresjö M
    Diabetes Metab Res Rev; 2009 May; 25(4):335-43. PubMed ID: 19382103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.
    Prat A; Biernacki K; Antel JP
    J Autoimmun; 2005 Mar; 24(2):119-24. PubMed ID: 15829404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.